MedPath

Moxifloxacin Hydrochloride

These highlights do not include all the information needed to use MOXIFLOXACIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for MOXIFLOXACIN HYDROCHLORIDE TABLETS. MOXIFLOXACIN HYDROCHLORIDE tablets, for oral useInitial U.S. Approval:1999

Approved
Approval ID

3c442cca-47f5-48e5-b718-c09413911687

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 21, 2019

Manufacturers
FDA

Novel Laboratories, Inc.

DUNS: 793518643

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Moxifloxacin Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code40032-034
Application NumberANDA207285
Product Classification
M
Marketing Category
C73584
G
Generic Name
Moxifloxacin Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateDecember 21, 2019
FDA Product Classification

INGREDIENTS (10)

MOXIFLOXACIN HYDROCHLORIDEActive
Quantity: 400 mg in 1 1
Code: C53598599T
Classification: ACTIM
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.